ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 906,40
0,66%
Dow Jones
44 556,04
0,30%
DAX
21 505,70
0,47%
Brent Oil
75,96
0,80%
Bitcoin
97 105,62
-4,24%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. 23andMe Holding Company (ME)

  7. 23andMe Holding Company (ME) Actualités

ME

23andMe (ME)

23andMe Holding Company
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ME
DateHeureSourceTitreSymboleSociété
31/01/202523h00Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ME23andMe Holding Company
31/01/202513h30GlobeNewswire Inc.23andMe Launches New Genetic Report on OsteoporosisNASDAQ:ME23andMe Holding Company
28/01/202523h25GlobeNewswire Inc.23andMe Special Committee Announces Exploration of Strategic AlternativesNASDAQ:ME23andMe Holding Company
28/01/202523h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
28/01/202523h15GlobeNewswire Inc.23andMe Reports Third Quarter Fiscal Year 2025 Financial ResultsNASDAQ:ME23andMe Holding Company
08/01/202513h30GlobeNewswire Inc.23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted TechnologyNASDAQ:ME23andMe Holding Company
21/11/202422h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
20/11/202413h30GlobeNewswire Inc.23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & InflammationNASDAQ:ME23andMe Holding Company
16/11/202403h17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ME23andMe Holding Company
15/11/202422h48Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ME23andMe Holding Company
13/11/202412h00Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ME23andMe Holding Company
12/11/202413h30GlobeNewswire Inc.23andMe Reports Second Quarter Fiscal Year 2025 Financial ResultsNASDAQ:ME23andMe Holding Company
11/11/202423h30GlobeNewswire Inc.23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the FutureNASDAQ:ME23andMe Holding Company
07/11/202423h54GlobeNewswire Inc.CORRECTION - 23andMe to Report Q2 FY2025 Financial ResultsNASDAQ:ME23andMe Holding Company
07/11/202413h30GlobeNewswire Inc.23andMe to Report Q2 FY2025 Financial ResultsNASDAQ:ME23andMe Holding Company
30/10/202422h00GlobeNewswire Inc.23andMe Regains Compliance With Nasdaq Listing RequirementsNASDAQ:ME23andMe Holding Company
29/10/202412h30GlobeNewswire Inc.23andMe Appoints Three New Independent Directors to BoardNASDAQ:ME23andMe Holding Company
17/10/202422h05GlobeNewswire Inc.23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the SouthNASDAQ:ME23andMe Holding Company
16/10/202414h15GlobeNewswire Inc.23andMe Announces Completion of 1-for-20 Reverse Stock SplitNASDAQ:ME23andMe Holding Company
11/10/202414h15GlobeNewswire Inc.23andMe Announces 1-for-20 Reverse Stock SplitNASDAQ:ME23andMe Holding Company
08/10/202413h00GlobeNewswire Inc.23andMe Announces Mathew Knowles as New Brand AmbassadorNASDAQ:ME23andMe Holding Company
25/09/202413h30GlobeNewswire Inc.23andMe Launches New Genetic Report on Likelihood of Frequent Emotional EatingNASDAQ:ME23andMe Holding Company
18/09/202412h13IH Market NewsMeta Strengthens Child Privacy on Instagram; Google Overturns $1.7 Billion Antitrust Fine; Snap Updates SpectaclesNASDAQ:ME23andMe Holding Company
17/09/202422h26GlobeNewswire Inc.Independent Directors of 23andMe Resign from BoardNASDAQ:ME23andMe Holding Company
15/09/202409h00GlobeNewswire Inc.23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 StudyNASDAQ:ME23andMe Holding Company
15/09/202409h00GlobeNewswire Inc.23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 TrialNASDAQ:ME23andMe Holding Company
12/09/202422h05GlobeNewswire Inc.One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All PopulationsNASDAQ:ME23andMe Holding Company
12/09/202412h02IH Market NewsNorfolk Southern CEO Fired, Ryanair Lowers Fare Forecast, 23andMe Considers Acquisition ProposalsNASDAQ:ME23andMe Holding Company
03/09/202413h30GlobeNewswire Inc.23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024NASDAQ:ME23andMe Holding Company
28/08/202413h30GlobeNewswire Inc.Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership ProgramNASDAQ:ME23andMe Holding Company
 Showing the most relevant articles for your search:NASDAQ:ME

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
COIN
SOLUSD
Solana
COIN
XRPUSD
Ripple
USI
USTECH100
US Tech 100
EU
BNP
BNP Paribas
EU
EN
Bouygues
EU
AF
Air FranceKLM
EU
MC
Lvmh Moet Hennessy Louis...
EU
PX4
SBF 120
NYSE
JPM
JP Morgan Chase
EU
GLE
Societe Generale
EU
PX1
CAC 40
NASDAQ
AMZN
Amazon.com
EU
SGO
Cie de SaintGobain
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces